These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 2436809

  • 1. Recognition of Rous sarcoma virus-induced tumor antigens by cytotoxic T lymphocytes (CTL): studies on specificity of killing by CTL employing H-2 congenic and recombinant mouse tumor cells.
    Haraguchi S, Kurakata S, Fujii T, Matsuo T, Yoshida TO.
    Cell Immunol; 1987 Apr 01; 105(2):340-54. PubMed ID: 2436809
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of target cell lysis by cytotoxic T lymphocytes (CTL) employing RSV-induced H-2 congenic and recombinant mouse tumor cells: demonstration of soluble mediators released from H-2-restricted CTL clones.
    Haraguchi S, Fujii T, Matsuo T, Yoshida TO.
    Cell Immunol; 1988 Apr 01; 112(2):279-92. PubMed ID: 2833355
    [Abstract] [Full Text] [Related]

  • 3. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH, Miller RG.
    J Immunol; 1985 Feb 01; 134(2):684-90. PubMed ID: 2578160
    [Abstract] [Full Text] [Related]

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 01; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 5. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y.
    J Immunol; 1988 Feb 01; 140(3):723-9. PubMed ID: 2448374
    [Abstract] [Full Text] [Related]

  • 6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA, Ruscetti SK, Longo DL, Jacobson S, Brown EJ, Zinn S, Kruisbeek AM.
    J Immunol; 1985 Jul 01; 135(1):703-13. PubMed ID: 2582053
    [Abstract] [Full Text] [Related]

  • 7. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR, Welsh RM.
    J Exp Med; 1993 Feb 01; 177(2):317-27. PubMed ID: 8093891
    [Abstract] [Full Text] [Related]

  • 8. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 9. Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones.
    Lukacher AE, Morrison LA, Braciale VL, Malissen B, Braciale TJ.
    J Exp Med; 1985 Jul 01; 162(1):171-87. PubMed ID: 2409206
    [Abstract] [Full Text] [Related]

  • 10. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
    Shinohara N, Hozumi N, Watanabe M, Bluestone JA, Johnson-Leva R, Sachs DH.
    J Immunol; 1988 Jan 01; 140(1):30-6. PubMed ID: 3257229
    [Abstract] [Full Text] [Related]

  • 11. Analysis of T-T lymphocytes and T-accessory cell interactions using cloned T cells: MHC I restricted cloned T cells activate MHC II restricted T helper cells.
    Brückner T, Di Pauli R.
    Cell Immunol; 1986 Apr 15; 99(1):182-95. PubMed ID: 2875800
    [Abstract] [Full Text] [Related]

  • 12. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H, Phillips JD, Green WR.
    J Immunol; 1987 Oct 01; 139(7):2464-73. PubMed ID: 2821116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F, Lilly F.
    J Exp Med; 1979 Nov 01; 150(5):1174-86. PubMed ID: 91655
    [Abstract] [Full Text] [Related]

  • 17. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.
    MacDonald HR, Glasebrook AL, Cerottini JC.
    J Exp Med; 1982 Dec 01; 156(6):1711-22. PubMed ID: 6983559
    [Abstract] [Full Text] [Related]

  • 18. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F, Collavo D, Zanovello P, Cerundolo V, Biasi G.
    Immunology; 1985 Feb 01; 54(2):265-74. PubMed ID: 2578429
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML, Parenza M, Parmiani G.
    J Natl Cancer Inst; 1983 Feb 01; 70(2):291-7. PubMed ID: 6571938
    [Abstract] [Full Text] [Related]

  • 20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M.
    J Immunol; 1984 Jun 01; 132(6):2775-82. PubMed ID: 6202760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.